$1.47
+0 (+0%)
At Close: Jun 08, 2026
NovaBay Pharmaceuticals, Inc. (NBY) Q2 2023 Earnings Call Transcript
02:40pm, Saturday, 12'th Aug 2023
NovaBay Pharmaceuticals, Inc. (NYSE:NBY ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Jody Cain - LHA, IR Justin Hall - Chief Executive Officer and General Counsel
NovaBay Pharmaceuticals to Present at the Emerging Growth Virtual Conference on May 31, 2023
06:50am, Wednesday, 24'th May 2023
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces th
Looking for Undervalued Penny Stocks? Use These Tips
06:35am, Monday, 22'nd May 2023
Understanding the stock market can be a challenging endeavor, yet it offers vast potential for substantial gains, particularly when it comes to penny stocks. Penny stocks, which typically trade below
Penny Stock Investing, 3 High-Growth Industries to Watch
06:00am, Sunday, 21'st May 2023
Take a look at these 3 industries to find penny stocks in The post Penny Stock Investing, 3 High-Growth Industries to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt
NovaBay Pharmaceuticals to Hold First Quarter 2023 Conference Call on May 11, 2023
06:50am, Thursday, 04'th May 2023
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2023 after market close o
Penny Stocks To Buy Now? 5 With Big News Today
10:22am, Friday, 21'st Apr 2023
Penny stocks news sparks momentum in the stock market today. The post Penny Stocks To Buy Now?
NovaBay Pharmaceuticals, Inc. (NBY) Q4 2022 Earnings Call Transcript
10:07pm, Thursday, 30'th Mar 2023
NovaBay Pharmaceuticals, Inc. (NYSE:NBY ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Jody Cain - Investor Relations Justin Hall - Chief Executive Officer and Gener
NovaBay Pharmaceuticals to Hold 2022 Fourth Quarter and Full Year Conference Call on March 30, 2023
06:50am, Thursday, 23'rd Mar 2023
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2022 after mark
NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023
06:50am, Tuesday, 31'st Jan 2023
EMERYVILLE, Calif.--( BUSINESS WIRE )--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that Justin Hall, CEO, will present a company overview at the virtual Sequire Biotechnology Confer
NovaBay Pharmaceuticals, Inc. (NBY) Q3 2022 Earnings Call Transcript
09:06pm, Monday, 14'th Nov 2022
NovaBay Pharmaceuticals, Inc. (NYSE:NBY ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Jody Cain - LHA Investor Relations Justin Hall - Chief Executive Officer an
NovaBay Pharmaceuticals to Present at the LD Micro Main Event XV
06:50am, Wednesday, 19'th Oct 2022
EMERYVILLE, Calif.
NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference
06:50am, Friday, 23'rd Sep 2022
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and s
NovaBay Pharmaceuticals to Present at the Virtual Life Sciences Investor Forum
06:50am, Tuesday, 13'th Sep 2022
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and s
NovaBay Pharmaceuticals (NBY) Stock Falls 13.03%: What Happened
01:15pm, Saturday, 10'th Sep 2022
The stock price of NovaBay Pharmaceuticals (NBY) fell by 13.03% yesterday. This is what happened.
NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q2 2022 Results - Earnings Call Transcript
10:50pm, Thursday, 11'th Aug 2022
NovaBay Pharmaceuticals, Inc. (NYSE:NBY ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Jody Cain - LHA Investor Relations Justin Hall - Chief Executive Officer and
Sign In
Buy NBY